Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

Trial Profile

Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Ferric carboxymaltose (Primary)
  • Indications Iron deficiency anaemia
  • Focus Adverse reactions; Registrational
  • Sponsors Zeria
  • Most Recent Events

    • 24 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 15 Jul 2016 New trial record
    • 12 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top